logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R,  et al.
2009-02-01 • Antiviral therapy
2009-02-01 • Antiviral therapy
BACKGROUND
The lack of HIV type-1 (HIV-1) viral load (VL) monitoring in resource-limited settings might favour the accumulation of resistance mutations and thus hamper second-line tr...
Journal Article
|
Research

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N,  et al.
2008-09-11 • Antiviral therapy
2008-09-11 • Antiviral therapy
BACKGROUND
The long-term maintenance of antiretroviral therapy (ART) remains an important issue, especially in limited-resource settings where additional barriers exist. A cross-sect...
Journal Article
|
Review

Provision of antiretroviral therapy in South Africa: the nuts and bolts

Bekker LG, Venter F, Cohen K, Goemare E, van Cutsem G,  et al.
2014-10-13 • Antiviral therapy
2014-10-13 • Antiviral therapy
Public sector antiretroviral provision had a slow start in South Africa despite a raging epidemic and a World AIDS conference that shed significant public light on the disparities of the...
Journal Article
|
Research

Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa

Stead D, Osler M, Boulle AM, Rebe K, Meintjes GA
2008-11-01 • Antiviral therapy
2008-11-01 • Antiviral therapy
BACKGROUND
In the public sector antiretroviral therapy (ART) programme in South Africa the standardized first-line regimen includes stavudine (d4T). Severe symptomatic hyperlactataem...